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Dear Editors
During the past six months, the COVID-19 pandemic has pro-
foundly altered society and affected health care systems on a
global scale. After initial reports of a new form of pneumonia in
early 2020, the situation rapidly evolved into a worldwide phe-
nomenon. The early experience with COVID-19 and its severe
respiratory symptoms reinforce the role of radiology in the
diagnosis and monitoring of patients. Since then, a plethora
of reports and scientific studies focused on the critical role of
imaging in the triage and diagnosis of patients [1]. We initially
learned that the COVID-19 pneumonia does present with char-
acteristic imaging findings in the acute stage [2, 3]. Although
not specific, these findings led to the broad use of either CT
imaging or chest radiographs for the assessment of COVID-19.
This was of particular interest since numerous studies observed
increased false negative rates for RT-PCR and abnormal CT
findings were detectable in otherwise asymptomatic
individuals.
Since February 2020 with the first cases of the novel
COVID-19 reported, the social, economic and particularly
medical landscape has widely adapted to the new situation.
In many countries, the so-called first wave of infections has
diminished, but a gradual re-increase of infections can be ex-
pected for fall and winter. Simultaneously, the first patients
that recovered from COVID-19 in early 2020 are now pre-
senting with sequelae from the initial Sars-CoV-2 infection.
We are presently facing patients that recovered from acute
COVID-19 pneumonia, some with ARDS, and that were
discharged having recovered from the acute illness.
Nevertheless, some of these patients report ongoing dyspnoea
and desaturate on exercise.
In the aftermath of a COVID-19 pneumonia, we observe in
some patients with respiratory symptoms a suggestive pattern
on CT images not previously reported in the context of
COVID-19. In a subgroup of cured patients, we encounter a
multifocal and/or anterior predominant pattern of
hypoattenuated areas in the lung parenchyma 3 months after
discharge. These areas frequently involve several adjacent, sec-
ondary lobules that are sharply demarcated from the surround-
ing lung parenchyma. In some cases, ground glass bands
circumscribing these hypoattenuated areas may be observed.
This suspected geographic hyperinflation of pulmonary lobules
is characterised by markedly decreased lung density.
Additionally, in some cases, the perilobular septae are bulging
towards the periphery, reinforcing the detectability and the au-
thenticity of this pattern on inspiratory CT scans. This air trap-
ping could also be confirmed on expiratory scans (Fig. 1), but
we believe that the distinct morphology and significant de-
crease intensity may not require systematic use of expiratory
CT scan protocols. In our experience, the identification of hy-
perinflated lobules inspiratory CT scans is facilitated by
employing narrow window settings and minimal intensity pro-
jections on a series reconstructedwith thin slices and soft kernel
(Figs. 1 and 2).
These CT findings are suggestive of small airways disease
(SAD). In patients who initially suffered fromARDS, addition-
al hallmark findings are reticulations, architectural distortions
with bronchiectasis and curvilinear lines, as well as
honeycombing in some cases. These CT features are attribut-
able to sequelae of alveolar damage/ARDS and therefore less
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characteristic of COVID-19 per se. When added together, post-
COVID-19 CT scans may resemble the so-called head-cheese
sign described in chronic hypersensitivity pneumonitis, a dis-
order that primarily affects the peribronchial area.
In the follow-up of symptomatic post-COVID-19 patients,
the reported signs are pivotal for the understanding of
pathological mechanisms involved with SARS-CoV-2 infec-
tion. Based on the CT patterns we encountered in cured
COVID-19 patients, we noticed that some patients display a
SAD predominance, while others present a predominance of
classical fibrotic changes or a mixed type pattern. Of note,
SAD was also reported in previous MERS, SARS and severe
Fig. 2 Three months after COVID-19 and ARDS, CT shows severe
architectural distortion and traction bronchiectasis (arrowhead in c and
d). These findings are frequent in patients that recovered from ARDS.
However, multi-lobular hypoattenuation pattern is also present (arrows)
on axial 1-mm-thick slices reconstructed with lung kernel (a) and 10-mm-
thick minimum intensity projections (mIP) slices with soft kernel (b), and
on coronal reformats 1-mm-thick reconstructed with lung kernel (c) and
10-mm-thick minimum intensity projections with soft kernel (d). The
mIP post-processing (b, d) highlights a geographic, lobular
hypoattenuation pattern that most likely represents multifocal small air-
ways disease. Presumably hyperinflated lobules further exhibit convex
perilobular septae towards normal lung parenchyma (small arrows) that
should correspond to an air trapping on expiration. Note that the normal
lung parenchyma (stars) is more easily assessed on mIP reformats with
narrow window settings (b, d), than on classical lung analysis (a, c). Note
pneumatoceles in subpleural location described in COVID-19 pneumonia
Fig. 1 Three-month follow-up CT scan of a patient after COVID-19
pneumonia presenting with exertional dyspnoea. Sharply demarcated
areas of hypoattenuating lung parenchyma are depicted in both upper
lobes (a). Reading the same acquisition on inspiration with narrow win-
dow settings on a series reconstructed in thin slices with soft kernel
facilitates the detection of these abnormal areas and enforces a mosaic-
like attenuation pattern (b). An additionally performed expiratory scan
confirms the SAD owing to air trapping that matches with several
hypoattenuating areas detected in (c). Note the predominant
hypoattenuation pattern in this case
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influenza infection and ARDS [4–6]. A limiting factor of our
findings is that not all patients initially received a baseline CT
and we can therefore not completely rule out preexisting con-
ditions such as SAD.
These preliminary findings highlight the importance of
imaging not only in the acute setting but also in the follow-
up of COVID-19. As we adapt to the pandemic, the death
toll is declining and hopefully mild to moderate infections
will continue to surpass severe cases. Nevertheless, health
care providers will face patients afflicted with long-term
impairment. We suggest to scrutinise post-COVID-19 CT
scans for findings of mosaic pattern, likely representing air
trapping, and indicative of a potential distal airway obstruc-
tion. Future research should further address the complex
association of SAD and reported vascular involvement [7,
8]. It has to be determined if and to what degree microvas-
cular thrombosis may contribute to bronchiolar constriction
or SAD [9].
Another critical aspect is the possible discrepancy between
imaging findings and the clinical presentation of patients. To
date, this relationship is still unclear.While some patients with
minimal findings on chest CT may show a severe decline in
lung function, there are patients with extensive diseases that
exhibit relatively normal lung function. A correlation between
imaging findings and moderate to severe disease course was
identified on initial presentation [10], but focused and well-
designed studies are needed to explore lung function loss and
dynamic CT findings in mid- to long-term follow-up of
COVID-19.
In the light of increasing numbers of patients suffering late
effects of COVID-19, we emphasise the importance of longi-
tudinal evaluation to assess potential reversibility of the ob-
served CT patterns.
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